Dilşad Sindel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dilşad Sindel has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Berrin Durmaz
Department of Physical Medicine and Rehabilitation, Ege University Faculty of Medicine, İzmir, Türkiye
2 shared publications - Burcu Metin Ökmen
Department of Physical Medicine and Rehabilitation, University of Health Sciences, Bursa Yüksek Ihtisas Training and Research Hospital, Bursa, Türkiye
2 shared publications - Cahit Kacar
Akdeniz University Hospital
2 shared publications - Fikriye Figen Ayhan
Department of Physical Medicine and Rehabilitation, Atılım University Faculty of Medicine, Ankara, Türkiye
2 shared publications - Gülcan Gürer
Department of Physical Medicine Rehabilitation and Rheumatology, School of Medicine, Adnan Menderes University, Aydın, Turkey
2 shared publications - Hasan Fatih Çay
Department of Physical Medicine Rehabilitation and Rheumatology, Antalya Training and Research Hospital, University of Health Sciences, Antalya, Turkey
2 shared publications
Latest Publications
- 2 April 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (5) , 400
Effectiveness of combined physical therapy and kinesio tape for acute hemiplegic shoulder pain: a retrospective study
- 2 April 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (5) , 400
Effectiveness of combined physical therapy and kinesio tape for acute hemiplegic shoulder pain: a retrospective study
- 5 June 2025
- Published by Springer Nature in Archives of Osteoporosis
- Vol. 20 (1) , 1-13
Digital integration and sociocultural tailoring in standardized care—FracTurk: the national digital fracture liaison service database by the Turkish Osteoporosis Society
Summary The FracTurk database integrates fracture liaison services with cultural and clinical practices in Türkiye, enhancing post-fracture care through digital tools. By tailoring treatment to the local context, it improves patient outcomes and reduces costs, with the potential to serve as a global model for culturally adapted healthcare solutions. Background Fracture liaison services (FLS) are specialized programs that aim to identify, treat, and manage patients who have experienced fragility fractures, with the overarching goal of preventing future fractures. Recognizing the need for a culturally appropriate and coordinated approach, the Turkish Osteoporosis Society has developed FracTurk, a national digitized FLS database tailored to the unique cultural, socioeconomic, and healthcare landscape of Türkiye. This paper provides an overview of the FracTurk system, detailing its development, potential benefits, and significance while also offering insights into future considerations for this initiative. By prioritizing digitalization and standardization within the FLS system, we aimed to pave a smooth patient pathway, ensuring a seamless journey through post-fracture care. Material and methods The FracTurk database was developed through a systematic process that involved the standardization and digitalization of patient follow-up forms and clinical practices across various institutions in Türkiye with international guidelines under the supervision of mentors certified by the International Osteoporosis Foundation, Capture the Fracture Initiative, which has been active for over 10 years in many countries. Additionally, the system incorporates clinical decision support tools and is customized to align with the Turkish cultural and healthcare landscape. Results Since its launch, the FracTurk database has been actively utilized by 25 users across 23 centers, with over 731 registered patients. The system continues to expand, demonstrating high levels of adoption and growth, indicating its increasing relevance and impact within the Turkish healthcare system. During the launch, the major difficulties and limitations encountered by the centers were discussed. Conclusion FracTurk constitutes a noteworthy step forward in digitizing and adapting FLS to the Turkish context. Although obstacles exist regarding data standardization and ensuring equitable access, the database demonstrates promise in enhancing patient outcomes, lowering healthcare expenditures, and serving as a template for other countries to emulate.
- 5 June 2025
- Published by Springer Nature in Archives of Osteoporosis
- Vol. 20 (1) , 1-13
Digital integration and sociocultural tailoring in standardized care—FracTurk: the national digital fracture liaison service database by the Turkish Osteoporosis Society
Summary The FracTurk database integrates fracture liaison services with cultural and clinical practices in Türkiye, enhancing post-fracture care through digital tools. By tailoring treatment to the local context, it improves patient outcomes and reduces costs, with the potential to serve as a global model for culturally adapted healthcare solutions. Background Fracture liaison services (FLS) are specialized programs that aim to identify, treat, and manage patients who have experienced fragility fractures, with the overarching goal of preventing future fractures. Recognizing the need for a culturally appropriate and coordinated approach, the Turkish Osteoporosis Society has developed FracTurk, a national digitized FLS database tailored to the unique cultural, socioeconomic, and healthcare landscape of Türkiye. This paper provides an overview of the FracTurk system, detailing its development, potential benefits, and significance while also offering insights into future considerations for this initiative. By prioritizing digitalization and standardization within the FLS system, we aimed to pave a smooth patient pathway, ensuring a seamless journey through post-fracture care. Material and methods The FracTurk database was developed through a systematic process that involved the standardization and digitalization of patient follow-up forms and clinical practices across various institutions in Türkiye with international guidelines under the supervision of mentors certified by the International Osteoporosis Foundation, Capture the Fracture Initiative, which has been active for over 10 years in many countries. Additionally, the system incorporates clinical decision support tools and is customized to align with the Turkish cultural and healthcare landscape. Results Since its launch, the FracTurk database has been actively utilized by 25 users across 23 centers, with over 731 registered patients. The system continues to expand, demonstrating high levels of adoption and growth, indicating its increasing relevance and impact within the Turkish healthcare system. During the launch, the major difficulties and limitations encountered by the centers were discussed. Conclusion FracTurk constitutes a noteworthy step forward in digitizing and adapting FLS to the Turkish context. Although obstacles exist regarding data standardization and ensuring equitable access, the database demonstrates promise in enhancing patient outcomes, lowering healthcare expenditures, and serving as a template for other countries to emulate.
- Open Access
- 1 February 2024
- Published by Galenos Yayinevi in Turkish Journal of Physical Medicine and Rehabilitation
- Vol. 70 (1) , 30-38
Pain types and risk factors in post-COVID-19
Objectives: This study aims to accurately evaluate pain lasting longer than three months and falls under the category of chronic pain and to determine the risk factors to follow up and treat properly and to develop appropriate diagnostic and treatment algorithms. Patients and methods: Between March 2021 and December 2021, a total of 437 patients (162 males, 275 females; mean age: 44±14.6 years; range, 12 to 82 years) who were referred to the participating centers due to pain complaints and were diagnosed with post-COVID-19 condition according to the criteria defined by the World Health Organization (WHO) were included in the study. The patients were divided into three groups as nociceptive pain, neuropathic pain, and central sensitization, based on the physician's clinical evaluation and the Self-Report Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) and Central Sensitization Inventory scores. Results: The most common diagnosis was nociceptive pain followed by central sensitization. Patients with nociceptive pain had less pain. It was found that not exercising regularly, having a chronic disease and being a woman were risk factors for central sensitization, having thyroid disease before COVID-19, and defining the current pain as very severe were risk factors for neuropathic pain. Conclusion: In the evaluation of post-COVID-19 pain, neuropathic pain and central sensitization should be also considered in addition to nociceptive pain and the severity of pain, systemic diseases and physical activity should be questioned.
- 1 February 2024
- Published by Galenos Yayinevi in Turkish Journal of Physical Medicine and Rehabilitation
- Vol. 70 (1) , 30-38
Open AccessPain types and risk factors in post-COVID-19
Objectives: This study aims to accurately evaluate pain lasting longer than three months and falls under the category of chronic pain and to determine the risk factors to follow up and treat properly and to develop appropriate diagnostic and treatment algorithms. Patients and methods: Between March 2021 and December 2021, a total of 437 patients (162 males, 275 females; mean age: 44±14.6 years; range, 12 to 82 years) who were referred to the participating centers due to pain complaints and were diagnosed with post-COVID-19 condition according to the criteria defined by the World Health Organization (WHO) were included in the study. The patients were divided into three groups as nociceptive pain, neuropathic pain, and central sensitization, based on the physician's clinical evaluation and the Self-Report Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) and Central Sensitization Inventory scores. Results: The most common diagnosis was nociceptive pain followed by central sensitization. Patients with nociceptive pain had less pain. It was found that not exercising regularly, having a chronic disease and being a woman were risk factors for central sensitization, having thyroid disease before COVID-19, and defining the current pain as very severe were risk factors for neuropathic pain. Conclusion: In the evaluation of post-COVID-19 pain, neuropathic pain and central sensitization should be also considered in addition to nociceptive pain and the severity of pain, systemic diseases and physical activity should be questioned.
- Open Access
- 31 December 2023
- Published by AVES YAYINCILIK A.Ş. in Archives of Rheumatology
- Vol. 38 (4) , 512-520
Correlation of clinical signs and magnetic resonance imaging findings in patients with lumbar spondylosis
Objectives: The purpose of the study was to contribute further to this debated topic by investigating the correlation of magnetic resonance imaging (MRI) findings with the clinical picture in lumbar spondylosis patients. Patients and methods: This multicenter retrospective study (as part of the epidemiological project of the TLAR-OASG [Turkish League Against Rheumatism-Osteoarthritis Study Group]) included 514 patients (101 males, 413 females; mean age: 63.6±10.8 years; range, 40 to 85 years) who were diagnosed as lumbar spondylosis by clinical examination and direct X-ray between December 2016 and June 2018. Demographic characteristics of patients, Visual Analog Scale for pain, presence of radiating pain, Roland-Morris disability questionnaire, straight leg raise test, deep tendon reflexes, neurogenic intermittent claudication symptoms, any decrease of muscle strength, and abnormality of sensation were recorded. Lumbar MRI findings of the patients were recorded as positive or negative in terms of disc herniation, intervertebral disc degeneration, root compression, osteophytes, spinal stenosis. Statistical analysis was done to assess the correlation between the clinical symptoms, physical examination, and MRI findings. Results: Correlation analysis of the MRI results and the clinical findings showed a significant correlation between straight leg raise test and root compression (p
- 31 December 2023
- Published by AVES YAYINCILIK A.Ş. in Archives of Rheumatology
- Vol. 38 (4) , 512-520
Open AccessCorrelation of clinical signs and magnetic resonance imaging findings in patients with lumbar spondylosis
Objectives: The purpose of the study was to contribute further to this debated topic by investigating the correlation of magnetic resonance imaging (MRI) findings with the clinical picture in lumbar spondylosis patients. Patients and methods: This multicenter retrospective study (as part of the epidemiological project of the TLAR-OASG [Turkish League Against Rheumatism-Osteoarthritis Study Group]) included 514 patients (101 males, 413 females; mean age: 63.6±10.8 years; range, 40 to 85 years) who were diagnosed as lumbar spondylosis by clinical examination and direct X-ray between December 2016 and June 2018. Demographic characteristics of patients, Visual Analog Scale for pain, presence of radiating pain, Roland-Morris disability questionnaire, straight leg raise test, deep tendon reflexes, neurogenic intermittent claudication symptoms, any decrease of muscle strength, and abnormality of sensation were recorded. Lumbar MRI findings of the patients were recorded as positive or negative in terms of disc herniation, intervertebral disc degeneration, root compression, osteophytes, spinal stenosis. Statistical analysis was done to assess the correlation between the clinical symptoms, physical examination, and MRI findings. Results: Correlation analysis of the MRI results and the clinical findings showed a significant correlation between straight leg raise test and root compression (p
- Open Access
- 15 May 2023
- Published by Galenos Yayinevi in Turkish Journal of Physical Medicine and Rehabilitation
- Vol. 69 (2) , 140-152
Osteoporosis: Spotlight on current approaches to pharmacological treatment
Despite the availability of safe and effective anti-osteoporosis treatments, osteoporosis continues to be undertreated. The increase in fragility fractures, which is the main clinical consequence of osteoporosis, is a major problem for healthcare systems of countries. A broad range of drugs including antiresorptive and anabolic agents are used in the pharmacological treatment of osteoporosis. Fracture risk assessment in drug selection is of utmost importance in terms of guiding treatment. The recommended thresholds for osteoporosis treatment decision making are based on major osteoporotic and hip fracture probabilities from the Fracture Risk Assessment Tool (FRAX®). Currently, antiresorptive agents are usually the first choice to increase bone mineral density (BMD) and reduce the fracture risk. Bisphosphonates and antiresorptive drugs such as denosumab, a nuclear factor kappa-B ligand (RANKL) inhibitor, are the most widely used drugs in the treatment of osteoporosis. Bisphosphonates alone are unlikely to provide long-term protection against fracture and restore BMD in patients with severe osteoporosis and high fracture risk. In such patients, treatment with an anabolic agent such as teriparatide, abaloparatide, or romosozumab should be ideally initiated to achieve maximal gain in bone mass and preserve the microarchitecture. Ideally, an antiresorptive drug should be continued to maintain gain in bone mass.
- 15 May 2023
- Published by Galenos Yayinevi in Turkish Journal of Physical Medicine and Rehabilitation
- Vol. 69 (2) , 140-152
Open AccessOsteoporosis: Spotlight on current approaches to pharmacological treatment
Despite the availability of safe and effective anti-osteoporosis treatments, osteoporosis continues to be undertreated. The increase in fragility fractures, which is the main clinical consequence of osteoporosis, is a major problem for healthcare systems of countries. A broad range of drugs including antiresorptive and anabolic agents are used in the pharmacological treatment of osteoporosis. Fracture risk assessment in drug selection is of utmost importance in terms of guiding treatment. The recommended thresholds for osteoporosis treatment decision making are based on major osteoporotic and hip fracture probabilities from the Fracture Risk Assessment Tool (FRAX®). Currently, antiresorptive agents are usually the first choice to increase bone mineral density (BMD) and reduce the fracture risk. Bisphosphonates and antiresorptive drugs such as denosumab, a nuclear factor kappa-B ligand (RANKL) inhibitor, are the most widely used drugs in the treatment of osteoporosis. Bisphosphonates alone are unlikely to provide long-term protection against fracture and restore BMD in patients with severe osteoporosis and high fracture risk. In such patients, treatment with an anabolic agent such as teriparatide, abaloparatide, or romosozumab should be ideally initiated to achieve maximal gain in bone mass and preserve the microarchitecture. Ideally, an antiresorptive drug should be continued to maintain gain in bone mass.
- 22 November 2022
- Published by Galenos Yayinevi in Turkish Journal of Physical Medicine and Rehabilitation
- Vol. 68 (4) , 538-542
Effects of different rehabilitation approaches after surgery for flexor tendon injuries of the hand: A Cochrane review summary with commentary
- 22 November 2022
- Published by Galenos Yayinevi in Turkish Journal of Physical Medicine and Rehabilitation
- Vol. 68 (4) , 538-542
Effects of different rehabilitation approaches after surgery for flexor tendon injuries of the hand: A Cochrane review summary with commentary
- Open Access
- 1 March 2022
- Published by Galenos Yayinevi in Turkish Thoracic Journal
- Vol. 23 (2) , 154-161
Pulmonary Rehabilitation in Coronavirus Disease 2019 Patients
Pulmonary rehabilitation,COVID-19,SARS-CoV-2
- 1 March 2022
- Published by Galenos Yayinevi in Turkish Thoracic Journal
- Vol. 23 (2) , 154-161
Open AccessPulmonary Rehabilitation in Coronavirus Disease 2019 Patients
Pulmonary rehabilitation,COVID-19,SARS-CoV-2
- 17 May 2018
- Published by Springer Nature in Rheumatology International
- Vol. 38 (8) , 1315-1331
2017 update of the Turkish League Against Rheumatism (TLAR) evidence-based recommendations for the management of knee osteoarthritis
In a Turkish League Against Rheumatism (TLAR) project, evidence-based recommendations for the management of knee osteoarthritis (OA) was developed for the first time in our country in 2012 (TLAR-2012). In accordance with developing medical knowledge and scientific evidence, recommendations were updated. The committee was composed of 22 physical medicine and rehabilitation specialists (4 have rheumatology subspeciality also) and an orthopaedic surgeon. Systematic literature search were applied on Pubmed, Embase, Cochrane and Turkish Medical Index for the dates between January the 1st 2012 and January the 29th of 2015. The articles were assessed for quality and classified according to hierarchy for the level of evidence, and the selected ones sent to committee members electronically. They were asked to develop new recommendations. In the meeting in 2015, the format of the recommendations was decided to be patient-based and considering the grade and the severity of the disease. By the discussion of the each item under the light of new evidences, the final recommendations were developed. Each item was voted electronically on a 10-cm visual analogue scale (VAS) and the strength of recommendation (SoR) was calculated. In the light of evidences, totally 11 titles of recommendations were developed; the first 7 were applicable to each patient in every stages of the disease, remaining were for defined specific clinical situations. The mean SoR value of the recommendations was between 7.44 and 9.93. TLAR-2012 recommendations were updated in a new format. We think that, present recommendations will be beneficial for the physicians who manage, as well as the patients who suffer from the disease.
- 17 May 2018
- Published by Springer Nature in Rheumatology International
- Vol. 38 (8) , 1315-1331
2017 update of the Turkish League Against Rheumatism (TLAR) evidence-based recommendations for the management of knee osteoarthritis
In a Turkish League Against Rheumatism (TLAR) project, evidence-based recommendations for the management of knee osteoarthritis (OA) was developed for the first time in our country in 2012 (TLAR-2012). In accordance with developing medical knowledge and scientific evidence, recommendations were updated. The committee was composed of 22 physical medicine and rehabilitation specialists (4 have rheumatology subspeciality also) and an orthopaedic surgeon. Systematic literature search were applied on Pubmed, Embase, Cochrane and Turkish Medical Index for the dates between January the 1st 2012 and January the 29th of 2015. The articles were assessed for quality and classified according to hierarchy for the level of evidence, and the selected ones sent to committee members electronically. They were asked to develop new recommendations. In the meeting in 2015, the format of the recommendations was decided to be patient-based and considering the grade and the severity of the disease. By the discussion of the each item under the light of new evidences, the final recommendations were developed. Each item was voted electronically on a 10-cm visual analogue scale (VAS) and the strength of recommendation (SoR) was calculated. In the light of evidences, totally 11 titles of recommendations were developed; the first 7 were applicable to each patient in every stages of the disease, remaining were for defined specific clinical situations. The mean SoR value of the recommendations was between 7.44 and 9.93. TLAR-2012 recommendations were updated in a new format. We think that, present recommendations will be beneficial for the physicians who manage, as well as the patients who suffer from the disease.
- 11 February 2016
- Published by Taylor & Francis in Endocrine Research
- Vol. 41 (3) , 248-260
The utility of dual-energy X-ray absorptiometry, calcaneal quantitative ultrasound, and fracture risk indices (FRAX® and Osteoporosis Risk Assessment Instrument) for the identification of women with distal forearm or hip fractures: A pilot study
Purpose: Dual-energy X-ray absorptiometry (DXA) is considered the “gold standard” in predicting osteoporotic fractures. Calcaneal quantitative ultrasound (QUS) variables are also known to predict fractures. Fracture risk assessment tools may also guide us for the detection of individuals at high risk for fractures. The aim of this case–control study was to evaluate the utility of DXA bone mineral density (BMD), calcaneal QUS parameters, FRAX® (Fracture Risk Assessment Tool), and Osteoporosis Risk Assessment Instrument (ORAI) for the discrimination of women with distal forearm or hip fractures. Materials and methods: This case–control study included 20 women with a distal forearm fracture and 18 women with a hip fracture as cases and 76 age-matched women served as controls. BMD at the spine, proximal femur, and radius was measured using DXA and acoustic parameters of bone were obtained using a calcaneal QUS device. FRAX® 10-year probability of fracture and ORAI scores were also calculated in all participants. Receiver operating characteristic (ROC) analysis was used to assess fracture discriminatory power of all the tools. Results: While all DXA BMD, and QUS variables and FRAX® fracture probabilities demonstrated significant areas under the ROC curves for the discrimination of hip-fractured women and those without, only 33% radius BMD, broadband ultrasound attenuation (BUA), and FRAX® major osteoporotic fracture probability calculated without BMD showed significant discriminatory power for distal forearm fractures. Conclusions: It can be concluded that QUS variables, particularly BUA, and FRAX® major osteoporotic fracture probability without BMD are good candidates for the identification of both hip and distal forearm fractures.
- 11 February 2016
- Published by Taylor & Francis in Endocrine Research
- Vol. 41 (3) , 248-260
The utility of dual-energy X-ray absorptiometry, calcaneal quantitative ultrasound, and fracture risk indices (FRAX® and Osteoporosis Risk Assessment Instrument) for the identification of women with distal forearm or hip fractures: A pilot study
Purpose: Dual-energy X-ray absorptiometry (DXA) is considered the “gold standard” in predicting osteoporotic fractures. Calcaneal quantitative ultrasound (QUS) variables are also known to predict fractures. Fracture risk assessment tools may also guide us for the detection of individuals at high risk for fractures. The aim of this case–control study was to evaluate the utility of DXA bone mineral density (BMD), calcaneal QUS parameters, FRAX® (Fracture Risk Assessment Tool), and Osteoporosis Risk Assessment Instrument (ORAI) for the discrimination of women with distal forearm or hip fractures. Materials and methods: This case–control study included 20 women with a distal forearm fracture and 18 women with a hip fracture as cases and 76 age-matched women served as controls. BMD at the spine, proximal femur, and radius was measured using DXA and acoustic parameters of bone were obtained using a calcaneal QUS device. FRAX® 10-year probability of fracture and ORAI scores were also calculated in all participants. Receiver operating characteristic (ROC) analysis was used to assess fracture discriminatory power of all the tools. Results: While all DXA BMD, and QUS variables and FRAX® fracture probabilities demonstrated significant areas under the ROC curves for the discrimination of hip-fractured women and those without, only 33% radius BMD, broadband ultrasound attenuation (BUA), and FRAX® major osteoporotic fracture probability calculated without BMD showed significant discriminatory power for distal forearm fractures. Conclusions: It can be concluded that QUS variables, particularly BUA, and FRAX® major osteoporotic fracture probability without BMD are good candidates for the identification of both hip and distal forearm fractures.
- Open Access
- 31 January 2012
- Published by AVES YAYINCILIK A.Ş. in Archives of Rheumatology
- Vol. 27 (1) , 038-046
Efficacy of Some Combined Conservative Methods in the Treatment of Carpal Tunnel Syndrome: A Randomized Controlled Clinical and Electrophysiological Trial
Objectives: In this study, we aimed to compare the efficacy of some conservative methods in combination with dexamethasone iontophoresis, ultrasound therapy or placebo iontophoresis (without dexamethasone) in the treatment of mild carpal tunnel syndrome (CTS). Patients and methods: Fifty-eight patients diagnosed with mild CTS confirmed by electromyography were included in the study. The subjects were divided randomly into three groups: (i) iontophoresis group-treated with dexamethasone iontophoresis (n=20); (ii) ultrasound group-treated with ultrasound (n=20), and (iii) placebo group-treated with placebo iontophoresis (n=18). All patients received one of these treatments in 15 sessions for three months in combination with physiotherapeutic procedures, such as tendon/nerve gliding exercises, night splinting and activity modifications. Wrist range of motion, muscle test, the Visual Analog Scale (VAS), handgrip test, pinch meter measurement, sensory testing with monofilaments, two-point discrimination test, Phalen's, reverse Phalen's, Tinnel's and carpal compression test, the Health Assessment Questionnaire (HAQ), the Boston Questionnaire (BQ) and electrophysiological assessment were performed at baseline, at the end of therapies and at threemonths during follow-up. Statistical analysis was performed using SPSS software (version 10.0 for Windows). Results: Statistically significant improvements in the clinical status of all groups were observed at the end of the study (p≤0.05). Compared to ultrasound group and placebo group, more successful outcomes were seen in the iontophoresis group, resulting in statistically significant improvements in the pinch meter measurements, monofilament and two-point discrimination tests, and in BQ scores at three months during follow-up (p≤0.05). A statistically significant improvement was also recorded in the electrophysiological measurements in the iontophoresis group and ultrasound group (p≤0.05). Conclusion: Our study results suggest that dexamethasone iontophoresis administration combined with tendon gliding exercises, splint and activity modification is reliable and effective in the treatment of patients with mild CTS. However, further large-scale studies are required to confirm these findings.
- 31 January 2012
- Published by AVES YAYINCILIK A.Ş. in Archives of Rheumatology
- Vol. 27 (1) , 038-046
Open AccessEfficacy of Some Combined Conservative Methods in the Treatment of Carpal Tunnel Syndrome: A Randomized Controlled Clinical and Electrophysiological Trial
Objectives: In this study, we aimed to compare the efficacy of some conservative methods in combination with dexamethasone iontophoresis, ultrasound therapy or placebo iontophoresis (without dexamethasone) in the treatment of mild carpal tunnel syndrome (CTS). Patients and methods: Fifty-eight patients diagnosed with mild CTS confirmed by electromyography were included in the study. The subjects were divided randomly into three groups: (i) iontophoresis group-treated with dexamethasone iontophoresis (n=20); (ii) ultrasound group-treated with ultrasound (n=20), and (iii) placebo group-treated with placebo iontophoresis (n=18). All patients received one of these treatments in 15 sessions for three months in combination with physiotherapeutic procedures, such as tendon/nerve gliding exercises, night splinting and activity modifications. Wrist range of motion, muscle test, the Visual Analog Scale (VAS), handgrip test, pinch meter measurement, sensory testing with monofilaments, two-point discrimination test, Phalen's, reverse Phalen's, Tinnel's and carpal compression test, the Health Assessment Questionnaire (HAQ), the Boston Questionnaire (BQ) and electrophysiological assessment were performed at baseline, at the end of therapies and at threemonths during follow-up. Statistical analysis was performed using SPSS software (version 10.0 for Windows). Results: Statistically significant improvements in the clinical status of all groups were observed at the end of the study (p≤0.05). Compared to ultrasound group and placebo group, more successful outcomes were seen in the iontophoresis group, resulting in statistically significant improvements in the pinch meter measurements, monofilament and two-point discrimination tests, and in BQ scores at three months during follow-up (p≤0.05). A statistically significant improvement was also recorded in the electrophysiological measurements in the iontophoresis group and ultrasound group (p≤0.05). Conclusion: Our study results suggest that dexamethasone iontophoresis administration combined with tendon gliding exercises, splint and activity modification is reliable and effective in the treatment of patients with mild CTS. However, further large-scale studies are required to confirm these findings.